EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark nordicPRO-C2 was filed as Word mark on 01/24/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/29/2023.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018827331 |
| Application date | January 24, 2023 |
| Publication date | March 22, 2023 |
| Entry date | June 29, 2023 |
| Expiration date | January 24, 2033 |
Trademark owner
Herlev Hovedgade 205
2730 Herlev
DK
2730 Herlev
DK
Trademark representatives
Calle Italia, 22 Local Bajo
03003 Alicante
ES
goods and services
5
Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; Biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; Diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; Diagnostic preparations, substances and materials; Medical diagnostic test strips; Diagnostic preparations for medical purposes; Diagnostic agents for medical use
42
Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; Design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; Design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; Scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; Laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis; Advice, information and assistance relating to the foregoing
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| September 11, 2023 | Transfer / Change of address, Published |
ID: 11018827331